- Home
- TCBS vs ITRM Comparison
TCBS vs ITRM Comparison
Compare TCBS & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBS
- ITRM
- Stock Information
- Founded
- TCBS 1934
- ITRM 2015
- Country
- TCBS United States
- ITRM Ireland
- Employees
- TCBS N/A
- ITRM N/A
- Industry
- TCBS Banks
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- TCBS Finance
- ITRM Health Care
- Exchange
- TCBS Nasdaq
- ITRM Nasdaq
- Market Cap
- TCBS 47.0M
- ITRM 49.5M
- IPO Year
- TCBS N/A
- ITRM 2018
- Fundamental
- Price
- TCBS $15.34
- ITRM $1.54
- Analyst Decision
- TCBS
- ITRM Strong Buy
- Analyst Count
- TCBS 0
- ITRM 1
- Target Price
- TCBS N/A
- ITRM $5.00
- AVG Volume (30 Days)
- TCBS 4.0K
- ITRM 671.4K
- Earning Date
- TCBS 02-20-2025
- ITRM 11-14-2024
- Dividend Yield
- TCBS 1.04%
- ITRM N/A
- EPS Growth
- TCBS N/A
- ITRM N/A
- EPS
- TCBS N/A
- ITRM N/A
- Revenue
- TCBS $9,858,000.00
- ITRM N/A
- Revenue This Year
- TCBS N/A
- ITRM N/A
- Revenue Next Year
- TCBS N/A
- ITRM N/A
- P/E Ratio
- TCBS N/A
- ITRM N/A
- Revenue Growth
- TCBS N/A
- ITRM N/A
- 52 Week Low
- TCBS $13.11
- ITRM $0.81
- 52 Week High
- TCBS $15.63
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- TCBS 59.62
- ITRM 39.39
- Support Level
- TCBS $15.00
- ITRM $1.58
- Resistance Level
- TCBS $15.59
- ITRM $2.10
- Average True Range (ATR)
- TCBS 0.31
- ITRM 0.14
- MACD
- TCBS 0.00
- ITRM -0.04
- Stochastic Oscillator
- TCBS 53.97
- ITRM 11.11
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.